Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
5.32
+0.16 (3.00%)
At close: Aug 13, 2025, 4:00 PM
5.32
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:36 AM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $188.96 million as of August 14, 2025. Its market cap has decreased by -68.75% in one year.
Market Cap
188.96M
Enterprise Value
-110.13M
1-Year Change
-68.75%
Ranking
Category
Stock Price
$5.32
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $188.96M, a decrease of -24.72%. That is a compound annual growth rate of -7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 183.45M | -70.03% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 572.76B |
| Johnson & Johnson | 414.55B |
| AbbVie | 350.34B |
| UnitedHealth Group | 236.59B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.36B |
| Novo Nordisk | 222.88B |